Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 7, 2015, Pages 1989-1992

  Vervoort, Jascha ^a   Xavier, Basil Britto ^a   Stewardson, Andrew ^b,c   Coenen, Samuel ^a   Godycki Cwirko, Maciek ^d   Adriaenssens, Niels ^a   Kowalczyk, Anna ^d   Lammens, Christine ^a   Harbarth, Stephan ^b   Goossens, Herman ^a   Malhotra Kumar, Surbhi ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

16S rDNA; 16S rRNA; Antibiotic resistance; Compositional changes; Culture independent; Faecal flora; Gastrointestinal flora; Stool; Urinary tract infections

Indexed keywords

NITROFURANTOIN; RNA 16S;

ACTINOBACTERIA; ANALYTICAL EQUIPMENT; ARTICLE; BACTERIAL GENE; BACTEROIDETES; BIFIDOBACTERIUM; CONTROLLED STUDY; DNA EXTRACTION; FECES; FECES MICROFLORA; FIRMICUTES; FOLLOW UP; HUMAN; METAGENOMICS; MOLLICUTES; PROTEOBACTERIA; PYROSEQUENCING; RNA ANALYSIS; URINARY TRACT INFECTION; VERRUCOMICROBIA;

EID: 84936932880     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv062     Document Type: Article

References (18)

1. Shah RR, Wade G. Reappraisal of the risk/benefit of nitrofurantoin: review of toxicity and efficacy. Adverse Drug React Acute Poisoning Rev 1989; 8: 183-201.
2. Conklin JD. The pharmacokinetics of nitrofurantoin and its related bioavailability. Antibiot Chemother 1978; 25: 233-52.
3. McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994; 33 Suppl A: 23-30.
4. Rafii F, Hansen EB Jr. Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract. Antimicrob Agents Chemother 1998; 42: 1121-6.
5. Vervoort J, Xavier BB, Stewardson A et al. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 2014; 58: 7225-33.
6. NIH. Manual of Procedures for Human Microbiome Project: Core Microbiome Sampling Protocol A. Bethesda, MD, USA: NIH, 2010.
7. Meyer F, Paarmann D, D'Souza M et al. The metagenomics RAST server-a public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinformatics 2008; 9: 386.
8. Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res 2002; 12: 656-64.
9. Cole JR, Chai B, Marsh TL et al. The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res 2003; 31: 442-3.
10. DeSantis TZ, Hugenholtz P, Larsen N et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72: 5069-72.
11. Pruesse E, Quast C, Knittel K et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 2007; 35: 7188-96.
12. Vieira AT, Teixeira MM, Martins FS. The role of probiotics and prebiotics in inducing gut immunity. Front Immunol 2013; 4: 445.
13. Vetrovsky T, Baldrian P. The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS One 2013; 8: e57923.
14. Poulsen HO, Johansson A, Granholm S et al. High genetic diversity of nitrofurantoin-or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread. J Antimicrob Chemother 2013; 68: 1974-7.
15. Pulcini C, Bush K, Craig WA et al. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis 2012; 54: 268-74.
16. ESCMID Study Group for Antibiotic Policies. ESGAP's Response to the European Commission's Consultation on "The Future of Pharmaceuticals for Human Use in Europe". 2007. https://www.escmid.org/fileadmin/src/media/PDFs/2News_Discussions/2Position_Papers/ESGAP_Position_Paper_ on_Antibiotic_Drug_Shortage.pdf.
17. Harbarth S, Filius PM, Natsch S et al. on behalf of the ESCMID Study Group on Antibiotic Policies (ESGAP). Shortage of Antimicrobial Agents in Europe: Results of an International Survey. 2007. https://www.escmid.org/fileadmin/src/media/PDFs/3Research_Projects/ESGAP/ESGAP_Poster_ ECCMID07_on_Antibiotic_Drug_Shortage.pdf.
18. Cunha BA. Nitrofurantoin-current concepts. Urology 1988; 32: 67-71.